{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:15:29Z","timestamp":1772151329009,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,13]]},"DOI":"10.7759\/cureus.101415","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:37:49Z","timestamp":1768297069000},"source":"Crossref","is-referenced-by-count":1,"title":["Amiodarone-Induced Thyrotoxicosis Presenting as Refractory Atrial Fibrillation in Hypertrophic Cardiomyopathy: A Case Report"],"prefix":"10.7759","author":[{"given":"Sofia","family":"Sequeira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Correia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Beatriz","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3275\/8298","article-title":"Amiodarone and the thyroid: a 2012 update","volume":"35","author":"Bogazzi F","year":"2012","unstructured":"Bogazzi F, Tomisti L, Bartalena L, Aghini-Lombardi F, Martino E. Amiodarone and the thyroid: a 2012 update. J Endocrinol Invest. 2012, 35:340-8. 10.3275\/8298","journal-title":"J Endocrinol Invest"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000486957","article-title":"2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction","volume":"7","author":"Bartalena L","year":"2018","unstructured":"Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M. 2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction. Eur Thyroid J. 2018, 7:55-66. 10.1159\/000486957","journal-title":"Eur Thyroid J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0828-282x(09)70512-4","article-title":"Amiodarone-induced thyrotoxicosis: a review","volume":"25","author":"Tsang W","year":"2009","unstructured":"Tsang W, Houlden RL. Amiodarone-induced thyrotoxicosis: a review. Can J Cardiol. 2009, 25:421-4. 10.1016\/s0828-282x(09)70512-4","journal-title":"Can J Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.22.2.0427","article-title":"The effects of amiodarone on the thyroid","volume":"22","author":"Martino E","year":"2001","unstructured":"Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on the thyroid. Endocr Rev. 2001, 22:240-54. 10.1210\/edrv.22.2.0427","journal-title":"Endocr Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.70.7.624","article-title":"Amiodarone induced thyrotoxicosis: diagnostic and therapeutic strategies","volume":"70","author":"Cardenas GA","year":"2003","unstructured":"Cardenas GA, Cabral JM, Leslie CA. Amiodarone induced thyrotoxicosis: diagnostic and therapeutic strategies. Cleve Clin J Med. 2003, 70:624-6, 628-31. 10.3949\/ccjm.70.7.624","journal-title":"Cleve Clin J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0180","article-title":"Approach to the patient with amiodarone-induced thyrotoxicosis","volume":"95","author":"Bogazzi F","year":"2010","unstructured":"Bogazzi F, Bartalena L, Martino E. Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 2010, 95:2529-35. 10.1210\/jc.2010-0180","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart","volume":"116","author":"Klein I","year":"2007","unstructured":"Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007, 116:1725-35. 10.1161\/CIRCULATIONAHA.106.678326","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/er.2003-0033","article-title":"Thyroid hormone action in the heart","volume":"26","author":"Kahaly GJ","year":"2005","unstructured":"Kahaly GJ, Dillmann WH. Thyroid hormone action in the heart. Endocr Rev. 2005, 26:704-28. 10.1210\/er.2003-0033","journal-title":"Endocr Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.08.042","article-title":"Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study","volume":"49","author":"Osman F","year":"2007","unstructured":"Osman F, Franklyn JA, Holder RL, Sheppard MC, Gammage MD. Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study. J Am Coll Cardiol. 2007, 49:71-81. 10.1016\/j.jacc.2006.08.042","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2012.402","article-title":"Subclinical hyperthyroidism and the risk of coronary heart disease and mortality","volume":"172","author":"Collet TH","year":"2012","unstructured":"Collet TH, Gussekloo J, Bauer DC, et al.. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 2012, 172:799-809. 10.1001\/archinternmed.2012.402","journal-title":"Arch Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2390","article-title":"Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial","volume":"97","author":"Eskes SA","year":"2012","unstructured":"Eskes SA, Endert E, Fliers E, Geskus RB, Dullaart RP, Links TP, Wiersinga WM. Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial. J Clin Endocrinol Metab. 2012, 97:499-506. 10.1210\/jc.2011-2390","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/454706-amiodarone-induced-thyrotoxicosis-presenting-as-refractory-atrial-fibrillation-in-hypertrophic-cardiomyopathy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:37:52Z","timestamp":1768297072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/454706-amiodarone-induced-thyrotoxicosis-presenting-as-refractory-atrial-fibrillation-in-hypertrophic-cardiomyopathy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.101415","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,13]]}}}